This PhD studentship is funded by Norwich Medical School. Funding comprises Home/EU fees and a stipend of £15,009 and £1000 per annum to support research training. Overseas applicants may apply but are required to fund the difference between home/EU and overseas tuition fees (in 2019/20 the difference is £14,373 for Norwich Medical School but fees are subject to an annual increase).
(i) Smith, J. G. W., et al. (2018). "Isogenic Pairs of hiPSC-CMs with Hypertrophic Cardiomyopathy/LVNC-Associated ACTC1 E99K Mutation Unveil Differential Functional Deficits." Stem Cell Reports 11(5): 1226-1243.
(ii) Mosqueira, D., et al. (2018). "CRISPR/Cas9 editing in human pluripotent stem cell-cardiomyocytes highlights arrhythmias, hypocontractility, and energy depletion as potential therapeutic targets for hypertrophic cardiomyopathy." Eur Heart J 39(43): 3879-3892.
(iii) Kondrashov, A., et al. (2018). "Simplified Footprint-Free Cas9/CRISPR Editing of Cardiac-Associated Genes in Human Pluripotent Stem Cells." Stem Cells Dev 27(6): 391-404.
(iv) Gyongyosi, M., et al. (2017). "Myocardial fibrosis: biomedical research from bench to bedside." Eur J Heart Fail 19(2): 177-191.
(v) Travers, J. G., et al. (2016). "Cardiac Fibrosis: The Fibroblast Awakens." Circ Res 118(6): 1021-1040.